Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Investing

Merck : MRK

All Merck Articles

1079 Articles

Chris Lange | Nov 11, 2015 at 4:28 PM EST

The 4 Stocks That Held Down the Dow Jones Industrial Average

November 11, 2015: Markets opened up on Wednesday but over the course of the day the markets drifted lower to…

Chris Lange | Nov 11, 2015 at 8:15 AM EST

Short Sellers Continue to Decrease Bets in Major Pharma

The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical…

Paul Ausick | Oct 28, 2015 at 4:01 PM EDT

The 4 Stocks That Buoyed the Dow on Wednesday

ThinkstockOctober 28, 2015: Markets opened higher on Wednesday and bounced of intra-day lows following the FOMC announcement which led investors…

Jon C. Ogg | Oct 27, 2015 at 10:05 AM EDT

How Pfizer Stacks Up Against Merck on Earnings

Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?

Chris Lange | Oct 27, 2015 at 9:05 AM EDT

Short Sellers Have Mixed Views on Major Pharma

The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Oct 26, 2015 at 1:50 PM EDT

What to Expect From Merck Earnings

Merckis expected to report its third-quarter financial results before the markets open on Tuesday.

Chris Lange | Oct 25, 2015 at 9:10 AM EDT

5 Dow Stocks Reporting Earnings This Week

24/7 Wall St. has put together a preview of Apple, Exxon and some of the major Dow Jones Industrial Average…

Lee Jackson | Oct 23, 2015 at 8:35 AM EDT

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

24/7 Wall St. screened the Merrill Lynch research universe for pharmaceutical stocks paying solid dividends that are rated Buy, and…

Paul Ausick | Oct 22, 2015 at 4:01 PM EDT

The 4 Stocks That Dominated the DJIA on Thursday

ThinkstockOctober 22, 2015: Markets opened higher on Thursday on a better-than-expected report on new claims for unemployment benefits, but the…

Paul Ausick | Oct 20, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the Dow Tuesday

ThinkstockOctober 20, 2015: Markets opened lower on again on Tuesday as investors trailed along after mixed Asian and European equities…

Paul Ausick | Oct 16, 2015 at 4:01 PM EDT

The 4 Stocks That Lifted the DJIA on Friday

ThinkstockOctober 16, 2015: Markets opened higher on Friday following an expected drop of 0.2% in U.S. industrial production and a…

Paul Ausick | Oct 13, 2015 at 4:01 PM EDT

The 4 Stocks That Sank the Dow on Tuesday

thinkstockOctober 13, 2015: Markets opened lower on Tuesday following disappointing economic data from China and a lack of any U.S.…

Chris Lange | Oct 12, 2015 at 9:25 AM EDT

Short Sellers Become More Selective on Major Pharma

The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Oct 7, 2015 at 4:01 PM EDT

The 4 Stocks That Boosted the Dow on Wednesday

thinkstockOctober 7, 2015: Markets opened higher on Wednesday tagging along on a rise in European equities. The upbeat start gave…

Chris Lange | Oct 3, 2015 at 9:15 AM EDT

5 Big FDA Decisions Expected in October

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of October and…

1 … 39 40 41 42 43 … 72

Merck : MRK

All Merck Articles

The 4 Stocks That Held Down the Dow Jones Industrial Average

Short Sellers Continue to Decrease Bets in Major Pharma

The 4 Stocks That Buoyed the Dow on Wednesday

How Pfizer Stacks Up Against Merck on Earnings

Short Sellers Have Mixed Views on Major Pharma

What to Expect From Merck Earnings

5 Dow Stocks Reporting Earnings This Week

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

The 4 Stocks That Dominated the DJIA on Thursday

The 4 Stocks That Weighed on the Dow Tuesday

The 4 Stocks That Lifted the DJIA on Friday

The 4 Stocks That Sank the Dow on Tuesday

Short Sellers Become More Selective on Major Pharma

The 4 Stocks That Boosted the Dow on Wednesday

5 Big FDA Decisions Expected in October

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

D-Wave Rewarded Patient Investors With 135% Gains but Recent Buyers Face a Brutal Reality

CPI Just Spelled Bad News for Social Security COLA — Even Though it May Not Seem That Way

1 Cyclical Dow Juggernaut With an Unshakable Moat to Buy

The Roth Conversion Strategy Affluent Couples Over 60 Are Using to Drain a $1.4 Million 401(k) Before RMDs Begin

Fidelity's 2026 Retirement Study Says 7-in-10 Americans Would Skip Traditional Retirement for Gig Work, a Business, or a New Career

The Roth Conversion Strategy Affluent Couples Over 60 Are Using to Drain a $1.4 Million 401(k) Before RMDs Begin

D-Wave Rewarded Patient Investors With 135% Gains but Recent Buyers Face a Brutal Reality

Merck : MRK

All Merck Articles

The 4 Stocks That Held Down the Dow Jones Industrial Average

Short Sellers Continue to Decrease Bets in Major Pharma

The 4 Stocks That Buoyed the Dow on Wednesday

How Pfizer Stacks Up Against Merck on Earnings

Short Sellers Have Mixed Views on Major Pharma

What to Expect From Merck Earnings

5 Dow Stocks Reporting Earnings This Week

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

The 4 Stocks That Dominated the DJIA on Thursday

The 4 Stocks That Weighed on the Dow Tuesday

The 4 Stocks That Lifted the DJIA on Friday

The 4 Stocks That Sank the Dow on Tuesday

Short Sellers Become More Selective on Major Pharma

The 4 Stocks That Boosted the Dow on Wednesday

5 Big FDA Decisions Expected in October

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

D-Wave Rewarded Patient Investors With 135% Gains but Recent Buyers Face a Brutal Reality

CPI Just Spelled Bad News for Social Security COLA — Even Though it May Not Seem That Way

1 Cyclical Dow Juggernaut With an Unshakable Moat to Buy

Featured Reads

The Roth Conversion Strategy Affluent Couples Over 60 Are Using to Drain a $1.4 Million 401(k) Before RMDs Begin

Fidelity's 2026 Retirement Study Says 7-in-10 Americans Would Skip Traditional Retirement for Gig Work, a Business, or a New Career